乙酰化修饰抑制α-synuclein的纤维化聚集
收稿日期: 2015-05-13
修回日期: 2016-04-18
网络出版日期: 2016-06-05
基金资助
Ministry of Science and Technology of China (2013CB910200);National Natural Science Foundation of China (21173258, 21120102038 and 21221064).
Lysine Acetylation Inhibits α-Synuclein Fibrillation
Received date: 2015-05-13
Revised date: 2016-04-18
Online published: 2016-06-05
Supported by
Ministry of Science and Technology of China (2013CB910200);National Natural Science Foundation of China (21173258, 21120102038 and 21221064).
天然无结构蛋白α-synuclein(α-syn)的纤维化聚集是帕金森病的特征表现.静电相互作用已被证明会显著影响α-syn的聚集.该文通过简单的赖氨酸乙酰化修饰改变蛋白的净电荷,研究静电效应对于α-syn的构象和纤维化聚集的影响.核磁共振(NMR)实验结果表明乙酰化后的α-syn仍然是无序结构,而且展现出比野生型更加伸展的构象.由于N端和C端都高度带负电荷,结构打开会更加暴露NAC区域,静电排斥和疏水作用共同存在,但ThT荧光实验发现乙酰化修饰抑制了它的纤维化聚集,因此我们认为这里静电排斥占据主导作用.这种依赖电荷的作用机理会帮助我们更好地理解α-syn的纤维化聚集,而乙酰化修饰也提供了一种抑制聚集的新方法.
吴琼 , 李从刚 , 翟紫凝 . 乙酰化修饰抑制α-synuclein的纤维化聚集[J]. 波谱学杂志, 2016 , 33(2) : 179 -187 . DOI: 10.11938/cjmr20160201
Fibrils of intrinsically disordered protein α-synuclein (α-syn) are hallmarks of Parkinson's disease. Electrostatic interactions are known to contribute significantly on α-syn aggregation. Here we studied how α-syn conformation and fibrillation were affected by changing the net charge of the protein via acetylation of lysine side chains. NMR spectroscopy results showed that lysine-acetylated α-syn remained disordered, and showed a more extended conformation, relative to wild-type protein. Acetylation inhibited α-syn fibrillation, revealed by thioflavin (ThT) fluorescence assay. The N- and C-terminals of the acetylated protein were highly negative charged, causing increased exposure of the non-amyloid-β component (NAC) region. It is proposed that, with the charge distribution in the acetylated protein, electrostatic repulsion, instead of hydrophobic effect, may contribute predominately to the aggregation. This charge-effect mechanism may constitute a new strategy to inhibit α-syn fibrillation.
Key words： liquid-state NMR; acetylation; fibrillation; α-synuclein
[1] Goedert M. Alpha-synuclein and neurodegenerative diseases[J]. Nat Rev Neurosci, 2001, 2(7):492-501.
[2] Trojanowski J Q, Lee V M Y. Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses[J]. Ann NY Acad Sci, 2003, 991:107-110.
[3] Spillantini M G, Crowther R A, Jakes R, et al. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies[J]. Proc Natl Acad Sci U S A, 1998, 95(11):6469-6473.
[4] Ulmer T S, Bax A, Cole N B, et al. Structure and dynamics of micelle-bound human alpha-synuclein[J]. J Biol Chem, 2005, 280(10):9595-9603.
[5] Bussell R J, Eliezer D. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins[J]. J Mol Biol, 2003, 329(4):763-778.
[6] El-Agnaf O M A, Bodles A M, Guthrie D J S, et al. The N-terminal region of non-A beta component of Alzheimer's Disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils[J]. Eur J Biochem, 1998, 258(1):157-163.
[7] Murray I V J, Giasson B I, Quinn S M, et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro[J]. Biochemistry, 2003, 42(28):8530-8540.
[8] Uversky V N. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation[J]. J Neurochem, 2007, 103(1):17-37.
[9] Wood S J, Wypych J, Steavenson S, et al. Alpha-synuclein fibrillogenesis is nucleation-dependent:Implications for the pathogenesis of Parkinson's disease[J]. J Biol Chem, 1999, 274(28):19509-19512.
[10] Uversky V N, Li J, Fink A L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation[J]. J Biol Chem, 2001, 276:10737-10744.
[11] Fernandez C O, Hoyer W, Zweckstetter M, et al. NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation[J]. Embo J, 2004, 23(10):2039-2046.
[12] Bertoncini C W, Jung Y S, Fernandez C O, et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein[J]. Proc Natl Acad Sci U S A, 2005, 102(5):1430-1435.
[13] Sung Y H, Eliezer D. Residual structure, backbone dynamics, and interactions within the synuclein family[J]. J Mol Biol, 2007, 372(3):689-707.
[14] Dedmon M M, Lindorff-Larsen K, Christodoulou J, et al. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations[J]. J Am Chem Soc, 2005, 127(2):476-477.
[15] Hoyer W, Cherny D, Subramaniam V, et al. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro[J]. Biochemistry, 2004, 43(51):16233-16242.
[16] Wu K P, Weinstock D S, Narayanan C, et al. Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations[J]. J Mol Biol, 2009, 391(4):784-796.
[17] Arnesen T, Van Damme P, Polevoda B, et al. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans[J]. Proc Natl Acad Sci U S A, 2009, 106(20):8157-8162.
[18] Hoyer W, Antony T, Cherny D, et al. Dependence of alpha-synuclein aggregate morphology on solution conditions[J]. J Mol Biol, 2002, 322(2):383-393.
[19] Shaw B F, Arthanari H, Narovlyansky M, et al. Neutralizing positive charges at the surface of a protein lowers its rate of amide hydrogen exchange without altering its structure or increasing its thermostability[J]. J Am Chem Soc, 2010, 132(49):17411-17425.
[20] Ferrage F, Zoonens M, Warschawski D E, et al. Slow diffusion of macromolecular assemblies by a new pulsed field gradient NMR method[J]. J Am Chem Soc, 2003, 125(9):2541-2545.
[21] Khurana R, Coleman C, Ionescu-Zanetti C, et al. Mechanism of thioflavin T binding to amyloid fibrils[J]. J Struct Biol, 2005, 151(3):229-238.
[22] Fink A L. The aggregation and fibrillation of alpha-synuclein[J]. Acc Chem Res, 2006, 39(9):628-634.
/
| 〈 |
|
〉 |